Takeda Pharmaceutical
357 hedge funds and large institutions have $1.82B invested in Takeda Pharmaceutical in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 173 increasing their positions, 58 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 347 → 357 (+10)
0.45% more ownership
Funds ownership: 2.63% → 3.09% (+0.45%)
Holders
357
Holding in Top 10
1
Calls
$30.6M
Puts
$1.41M
Top Buyers
| 1 | +$113M | |
| 2 | +$98.6M | |
| 3 | +$53.7M | |
| 4 |
CWP
Capital Wealth Planning
Naples,
Florida
|
+$15.6M |
| 5 |
Goldman Sachs
New York
|
+$14.3M |
Top Sellers
| 1 | -$45M | |
| 2 | -$29.7M | |
| 3 | -$24.3M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$15M |
| 5 |
Millennium Management
New York
|
-$13.9M |
